Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24

Articles

51061 items
12:00 AM, Aug 25, 2000  |  BC Extra | Company News

Advanced Biotherapy names CEO

ADVB, which is developing cytokines to treat autoimmune diseases, hired Paul Marangos as chairman and CEO. Marangos was formerly chairman and CEO at Cypros, which last year merged with RiboGene to form Questcor (QSC) ...
12:00 AM, Aug 25, 2000  |  BC Extra | Company News

Advanced Tissue submits PMA

ATIS and partner Smith & Nephew (SNN) submitted a PMA to the FDA for ATIS's Dermagraft engineered human dermis with synthetic epidermis to treat diabetic foot ulcers. Earlier this year, the partners modified the inclusion...
12:00 AM, Aug 25, 2000  |  BC Extra | Company News

FDA accepts Pharmacia's Celebrex sNDA for filing

PHA said the FDA has accepted for filing its sNDA requesting label changes to indicate that Celebrex celecoxib can be safely used over a longer term. The filing is based on 13-month safety data from...
12:00 AM, Aug 25, 2000  |  BC Extra | Clinical News

Vion starts Tapet Phase I

VION began a U.S. Phase I study in 20-30 advanced cancer patients to determine the safety and tolerablility of intravenous administration of its Tapet vector, which uses genetically engineered Salmonella bacteria to target and accumulate...
12:00 AM, Aug 25, 2000  |  BC Extra | Financial News

Genencor sells shoe

Genencor (GCOR) raised $18.9 million through the sale of 1.05 million shares at $18 authorized to cover overallotments in its July IPO. The sale brings to $144.9 million the total raised in the offering, underwritten...
12:00 AM, Aug 25, 2000  |  BC Extra | Financial News

AeroGen files for IPO

AeroGen (Sunnyvale, Calif.), a developer of products for the delivery of drugs via the lungs, filed to raise up to $57.5 million in an IPO through Chase H&Q; CIBC World Markets; and SG Cowen. No...
12:00 AM, Aug 25, 2000  |  BC Extra | Financial News

Cosmix raises EUR5 million

Cosmix (Braunschweig, Germany) raised EUR5 million ($4.5 million) in a second round financing. Investors included Apax Europe IV; and Buchler. The company's Cosmix-plexing technology identifies peptides with high affinity and specificity to enzymes, receptors or...
12:00 AM, Aug 24, 2000  |  BC Extra | Company News

Draxis receives FDA approval

The FDA granted marketing approval to DRAX's Draximage Inc. subsidiary (Kirkland, Quebec) for its BrachySeed iodine-125 brachytherapy seed product to treat prostate cancer. BrachySeed received Canadian marketing approval in May....
12:00 AM, Aug 24, 2000  |  BC Extra | Company News

Incyte signs distribution deals

INCY partnered with 19 companies in Asia, Europe, Latin America and the U.S. to market and distribute its custom genomics technologies, including its LifeSeq Gene-by-Gene sets of clone reagents and related sequence data....
12:00 AM, Aug 24, 2000  |  BC Extra | Top Story

Biotech market roars

The biotech market charged forward Thursday on the heels of big moves in the discovery group that were driven by Wednesday's announcement of the NIH's guidelines for NIH-funded human pluripotent stem cell research (see...

Pages